Article
Version 1
Preserved in Portico This version is not peer-reviewed
Vestibular Drop Attack: An Analysis of the Therapeutic Response
Version 1
: Received: 12 September 2023 / Approved: 12 September 2023 / Online: 13 September 2023 (02:35:28 CEST)
A peer-reviewed article of this Preprint also exists.
Carmona, S.; Fernandez, M.G.; Espona, C.D. Vestibular Drop Attack: An Analysis of the Therapeutic Response. Audiol. Res. 2024, 14, 27-34. Carmona, S.; Fernandez, M.G.; Espona, C.D. Vestibular Drop Attack: An Analysis of the Therapeutic Response. Audiol. Res. 2024, 14, 27-34.
Abstract
The present study evaluates the response to betahistine in patients who presented vestibular drops attacks in the context of Ménière's disease (MD) and the factors that can predict an unfavorable response to it. A total of 43 patients were analyzed, out of which 33 were diagnosed with MD. It is a descriptive, cross-sectional study with retrospective data collection. Data as regards age, accompanying symptoms, etiological diagnosis and response to MD treatment were collected. A statistical analysis was carried out, and we found that the disease evolution time and specific alterations in the vestibulospinal and oculomotor physical examination present an unfavorable response to betahistine, as opposed to the use of intratympanic gentamicin, with which symptomatic control is achieved in 100% of the cases.
Keywords
Vestibular drop attacks; tumarkin attacks, Ménière’s disease
Subject
Biology and Life Sciences, Neuroscience and Neurology
Copyright: This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Comments (0)
We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.
Leave a public commentSend a private comment to the author(s)
* All users must log in before leaving a comment
